CURTIS THILL: Open Payments
NPI 1912016858 · MARENGO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 18 payments from 6 companies in 2025. Trend: 2023 $321 · 2024 $570 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| ABBVIE INC. | 5 | $91 |
| Exact Sciences Corporation | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: FARXIGA, CAPLYTA, VRAYLAR, TRELEGY ELLIPTA, MAVYRET, The Cologuard Plus Collection Kit, Cologuard Collection Kit, Kerendia.
Industry payments across IN — which companies pay providers there.
